Future of GLP-1 Medications: In Development: Oral formulations (Rybelsus exists but less effective) Monthly injection versions Triple agonist medications (GIP/GLP-1/glucagon) Combinations with other weight loss mechanisms The GLP-1 class will likely dominate weight loss treatment for the next decade while continuing to improve
It's legal to create, what's called, a compounded version of these meds, and that is largely what these telehealth companies are selling online
And they just were like, you know
2023;21(10):2560-9.e15
The list includes medications with unique pharmacokinetic properties, such as: Clinically, these drugs are primarily prescribed for the treatment of type 2 diabetes, but they also have additional benefits in obesity management, cardiovascular risk reduction, and, to some extent, fatty liver disease